We are pleased to present the second in a series of webinars relating to Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S. which provides expert guidance and practical know-how for lawyers working in this growing area of the law.
The second webinar, Biosimilars Patent Challenges At The PTAB, will take place tomorrow, Wednesday, May 6th. Goodwin experts, Christine Armellino, James Breen, Molly Grammel and Emily Rapalino will explore topics including the type of biologics patents being challenged at the PTAB and the success rate for each type, the timing of challenges relative to aBLA filing/litigation, the number of challenges for a given patent/given drug, how these PTAB challenges impact biologic manufacturers and strategies for biosimilars companies in light of PTAB statistics. Click here to register.
Visit this page to register for future webinars in this series.